|4Aug 5, 6:37 PM ET

Gilde Healthcare Holding B.V. 4

4 · SHOULDER INNOVATIONS, INC. · Filed Aug 5, 2025

Insider Transaction Report

Form 4
Period: 2025-08-01
Transactions
  • Conversion

    Common Stock

    2025-08-01+1,743,1561,743,156 total(indirect: See footnote)
  • Purchase

    Common Stock

    2025-08-01$15.00/sh+100,000$1,500,0002,380,482 total(indirect: See footnote)
  • Conversion

    Series D Convertible Preferred Stock

    2025-08-0133,259,4240 total(indirect: See footnote)
    Common Stock (1,743,156 underlying)
  • Conversion

    Series E Convertible Preferred Stock

    2025-08-0110,252,1880 total(indirect: See footnote)
    Common Stock (537,326 underlying)
  • Conversion

    Common Stock

    2025-08-01+537,3262,280,482 total(indirect: See footnote)
Footnotes (2)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis without payment or further consideration. There was no expiration date for the shares of preferred stock.
  • [F2]Held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde Healthcare V Management B.V. is the managing director of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare V Management B.V. is owned by Gilde Healthcare Holding B.V. The managing partners of Gilde Healthcare Holding B.V. are Manapouri B.V. (of which Edwin de Graaf is the owner and managing director) and Martemanshurk B.V. (of which Pieter van der Meer is the owner and managing director). Geoff Pardo is a partner at Gilde and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Mr. Pardo disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4